Healthcare Professionals, Welcome to LifebankUSA^®
Not all cord blood banks are the same. Only LifebankUSA offers the opportunity to bank more stem cells, for more lifesaving potential.

Only LifebankUSA banks stem cells from 2 usable sources of stem cell-rich blood: the umbilical cord and the placenta

Placenta-Cord banking provides:

More CD34+ cells, clinically proven to provide greater transplant success and survival, according to several recent studies:

CD34+ dose is one of the most important determinants of successful hematopoietic recovery and transplant engraftment¹
Higher number of CD34+ stem cells transplanted may overcome some degree of human leukocyte antigen (HLA) mismatch-an important advantage for biological family member use
HLA is a genetic marker of "self" that prevents the immune system from attacking the body's own tissues
As a baby grows into adulthood, he or she will require more CD34+ stem cells for transplant

"Studies of UCBT [umbilical cord blood transplantation] have consistently shown that the cell dose is strongly correlated with hematopoietic engraftment.

- Dr. Nanesh Kamani, et al
Biol Blood Marrow Transplant. 2008;14(1):1-6

"...CB [cord blood] CD34+/CD38- subsets. proliferate more rapidly, and generate significantly more HPCs [hematopoietic progenitor cells] compared to similar populations in marrow..These results demonstrate for the first time the presence and quantity of processed CB CD34+/CD38- subsets and its significant correlation with other CB HPCs."

-Dr. Mitchell S. Cairo et al
Transfusion. 2005;45(6):856-866.

More mesenchymal-like stem cells (eg, CD105+200+), which may be beneficial for treatments in regenerative medicine

In the laboratory, CD105+200+ stem cells have been shown to possess osteogenic, chondrogenic, and adipogenic differentiation

"Mesenchymal stem cells have the capacity to differentiate into connective tissue and musculoskeletal cells for tissue engineering, autologous implantation/transplantation and regenerative medicine."

-Dr. Stephen M. Richardson et al
J Cell Physiol. 2010;222(1):23-32.

More stem cells overall

"Several authors performed studies of the role of cell dose and HLA in donor choice. They all agree that cell dose is the most important factor compared with HLA."

-Dr. Eliane Gluckman et al
Curr Opin Immunol. 2006;18(5):565-570

Whether your patients want to bank both the placenta and cord blood or simply cord blood alone, there are many important reasons to choose LifebankUSA.

We offer industry-leading purity,* a heparin-free collection bag, and fast delivery of babies' cord blood to our labs. And we are backed by the reputation and resources of Celgene Corporation

But don't take our word for it-read what our clients say. In a recent survey, more than 99% of parents said they would bank with us again and recommend LifebankUSA to their families and friends.^✝

*Purity is defined as an absence of red blood cells.^✝ Based on responses from a 2010 customer survey.

"I feel strongly that LifebankUSA is a very reliable source of banking and collection. I know the people running it. I have experience with them... Actually, I recommend it to my friends."

-Dr. Lolie Yu
Director, Bone Marrow Transplant program
Louisiana State University Health Sciences Center/Children's Hospital
New Orleans, Louisiana

References:

1.Gluckman E, Rocha V. Donor selection for unrelated cord blood transplants. Curr Opin Immunol. 2006;18(5):565-570.
2.Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Biol Blood Marrow Transplant. 2008;14(3):316-322.